The Nuclear Medicine-Radiopharmaceuticals market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Nuclear Medicine-Radiopharmaceuticals market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Nuclear Medicine-Radiopharmaceuticals market. The report focuses on well-known providers in the global Nuclear Medicine-Radiopharmaceuticals industry, market segments, competition, and the macro environment.
Under COVID-19 Outbreak, how the Nuclear Medicine-Radiopharmaceuticals Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
Key players in the global Nuclear Medicine-Radiopharmaceuticals market covered in Chapter 4:
Alliance Medical (UK)
Bayer HealthCare Medical Care (US)
Lantheus Medical Imaging Inc (US)
Positron Corporation (US)
Alseres Pharmaceuticals, Inc (US)
Ion Beam Applications S.A (Belgium)
Nordion, Inc. (Canada)
Avid Radiopharmaceuticals (US)
Actinium Pharmaceuticals Inc (US)
Mallinckrodt Pharmaceuticals (Ireland)
Siemens Healthcare (US)
Cardinal Health, Inc (US)
Advanced Medical Isotope Corporation (US)
Immunomedics, Inc. (US)
Bracco Imaging S.p.A (Italy)
Triad Isotopes, Inc. (US)
Peregrine Pharmaceuticals, Inc. (US)
GE Healthcare (UK)
Medi-Radiopharma Ltd (Hungary)
Jubilant Pharma (India)
In Chapter 11 and 13.3, on the basis of types, the Nuclear Medicine-Radiopharmaceuticals market from 2015 to 2026 is primarily split into:
Diagnostic Medicine
Therapeutic Medicine
In Chapter 12 and 13.4, on the basis of applications, the Nuclear Medicine-Radiopharmaceuticals market from 2015 to 2026 covers:
SPECT
PET
Therapeutic
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Global Nuclear Medicine-Radiopharmaceuticals Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Nuclear Medicine-Radiopharmaceuticals Market Share by Type (2020-2026)
1.5.2 Diagnostic Medicine
1.5.3 Therapeutic Medicine
1.6 Market by Application
1.6.1 Global Nuclear Medicine-Radiopharmaceuticals Market Share by Application (2020-2026)
1.6.2 SPECT
1.6.3 PET
1.6.4 Therapeutic
1.7 Nuclear Medicine-Radiopharmaceuticals Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Nuclear Medicine-Radiopharmaceuticals Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter's Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of Nuclear Medicine-Radiopharmaceuticals Market
3.1 Value Chain Status
3.2 Nuclear Medicine-Radiopharmaceuticals Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals
3.2.3 Labor Cost of Nuclear Medicine-Radiopharmaceuticals
3.2.3.1 Labor Cost of Nuclear Medicine-Radiopharmaceuticals Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Alliance Medical (UK)
4.1.1 Alliance Medical (UK) Basic Information
4.1.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.1.3 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.1.4 Alliance Medical (UK) Business Overview
4.2 Bayer HealthCare Medical Care (US)
4.2.1 Bayer HealthCare Medical Care (US) Basic Information
4.2.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.2.3 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.2.4 Bayer HealthCare Medical Care (US) Business Overview
4.3 Lantheus Medical Imaging Inc (US)
4.3.1 Lantheus Medical Imaging Inc (US) Basic Information
4.3.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.3.3 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.3.4 Lantheus Medical Imaging Inc (US) Business Overview
4.4 Positron Corporation (US)
4.4.1 Positron Corporation (US) Basic Information
4.4.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.4.3 Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.4.4 Positron Corporation (US) Business Overview
4.5 Alseres Pharmaceuticals, Inc (US)
4.5.1 Alseres Pharmaceuticals, Inc (US) Basic Information
4.5.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.5.3 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.5.4 Alseres Pharmaceuticals, Inc (US) Business Overview
4.6 Ion Beam Applications S.A (Belgium)
4.6.1 Ion Beam Applications S.A (Belgium) Basic Information
4.6.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.6.3 Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.6.4 Ion Beam Applications S.A (Belgium) Business Overview
4.7 Nordion, Inc. (Canada)
4.7.1 Nordion, Inc. (Canada) Basic Information
4.7.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.7.3 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.7.4 Nordion, Inc. (Canada) Business Overview
4.8 Avid Radiopharmaceuticals (US)
4.8.1 Avid Radiopharmaceuticals (US) Basic Information
4.8.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.8.3 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.8.4 Avid Radiopharmaceuticals (US) Business Overview
4.9 Actinium Pharmaceuticals Inc (US)
4.9.1 Actinium Pharmaceuticals Inc (US) Basic Information
4.9.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.9.3 Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.9.4 Actinium Pharmaceuticals Inc (US) Business Overview
4.10 Mallinckrodt Pharmaceuticals (Ireland)
4.10.1 Mallinckrodt Pharmaceuticals (Ireland) Basic Information
4.10.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.10.3 Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.10.4 Mallinckrodt Pharmaceuticals (Ireland) Business Overview
4.11 Siemens Healthcare (US)
4.11.1 Siemens Healthcare (US) Basic Information
4.11.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.11.3 Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.11.4 Siemens Healthcare (US) Business Overview
4.12 Cardinal Health, Inc (US)
4.12.1 Cardinal Health, Inc (US) Basic Information
4.12.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.12.3 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.12.4 Cardinal Health, Inc (US) Business Overview
4.13 Advanced Medical Isotope Corporation (US)
4.13.1 Advanced Medical Isotope Corporation (US) Basic Information
4.13.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.13.3 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.13.4 Advanced Medical Isotope Corporation (US) Business Overview
4.14 Immunomedics, Inc. (US)
4.14.1 Immunomedics, Inc. (US) Basic Information
4.14.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.14.3 Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.14.4 Immunomedics, Inc. (US) Business Overview
4.15 Bracco Imaging S.p.A (Italy)
4.15.1 Bracco Imaging S.p.A (Italy) Basic Information
4.15.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.15.3 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.15.4 Bracco Imaging S.p.A (Italy) Business Overview
4.16 Triad Isotopes, Inc. (US)
4.16.1 Triad Isotopes, Inc. (US) Basic Information
4.16.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.16.3 Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.16.4 Triad Isotopes, Inc. (US) Business Overview
4.17 Peregrine Pharmaceuticals, Inc. (US)
4.17.1 Peregrine Pharmaceuticals, Inc. (US) Basic Information
4.17.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.17.3 Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.17.4 Peregrine Pharmaceuticals, Inc. (US) Business Overview
4.18 GE Healthcare (UK)
4.18.1 GE Healthcare (UK) Basic Information
4.18.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.18.3 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.18.4 GE Healthcare (UK) Business Overview
4.19 Medi-Radiopharma Ltd (Hungary)
4.19.1 Medi-Radiopharma Ltd (Hungary) Basic Information
4.19.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.19.3 Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.19.4 Medi-Radiopharma Ltd (Hungary) Business Overview
4.20 Jubilant Pharma (India)
4.20.1 Jubilant Pharma (India) Basic Information
4.20.2 Nuclear Medicine-Radiopharmaceuticals Product Profiles, Application and Specification
4.20.3 Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Market Performance (2015-2020)
4.20.4 Jubilant Pharma (India) Business Overview
5 Global Nuclear Medicine-Radiopharmaceuticals Market Analysis by Regions
5.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Regions
5.1.1 Global Nuclear Medicine-Radiopharmaceuticals Sales by Regions (2015-2020)
5.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue by Regions (2015-2020)
5.2 North America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.3 Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
5.6 South America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6 North America Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries
6.1 North America Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries
6.1.1 North America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
6.1.2 North America Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)
6.1.3 North America Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
6.2 United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.2.1 United States Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
6.3 Canada Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
6.4 Mexico Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7 Europe Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries
7.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries
7.1.1 Europe Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
7.1.2 Europe Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)
7.1.3 Europe Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
7.2 Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.2.1 Germany Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
7.3 UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.3.1 UK Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
7.4 France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.4.1 France Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
7.5 Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.5.1 Italy Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
7.6 Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.6.1 Spain Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
7.7 Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
7.7.1 Russia Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
8 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries
8.1 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
8.2 China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.2.1 China Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
8.3 Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.3.1 Japan Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
8.4 South Korea Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.4.1 South Korea Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
8.5 Australia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.6 India Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.6.1 India Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
8.7 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
9 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries
9.1 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
9.2 Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.3 UAE Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Egypt Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.5 Nigeria Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
9.6 South Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10 South America Nuclear Medicine-Radiopharmaceuticals Market Analysis by Countries
10.1 South America Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Countries
10.1.1 South America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
10.1.2 South America Nuclear Medicine-Radiopharmaceuticals Revenue by Countries (2015-2020)
10.1.3 South America Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
10.2 Brazil Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.2.1 Brazil Nuclear Medicine-Radiopharmaceuticals Market Under COVID-19
10.3 Argentina Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.4 Columbia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
10.5 Chile Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
11 Global Nuclear Medicine-Radiopharmaceuticals Market Segment by Types
11.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Types (2015-2020)
11.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Types (2015-2020)
11.2 Diagnostic Medicine Sales and Price (2015-2020)
11.3 Therapeutic Medicine Sales and Price (2015-2020)
12 Global Nuclear Medicine-Radiopharmaceuticals Market Segment by Applications
12.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Nuclear Medicine-Radiopharmaceuticals Sales and Market Share by Applications (2015-2020)
12.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Applications (2015-2020)
12.2 SPECT Sales, Revenue and Growth Rate (2015-2020)
12.3 PET Sales, Revenue and Growth Rate (2015-2020)
12.4 Therapeutic Sales, Revenue and Growth Rate (2015-2020)
13 Nuclear Medicine-Radiopharmaceuticals Market Forecast by Regions (2020-2026)
13.1 Global Nuclear Medicine-Radiopharmaceuticals Sales, Revenue and Growth Rate (2020-2026)
13.2 Nuclear Medicine-Radiopharmaceuticals Market Forecast by Regions (2020-2026)
13.2.1 North America Nuclear Medicine-Radiopharmaceuticals Market Forecast (2020-2026)
13.2.2 Europe Nuclear Medicine-Radiopharmaceuticals Market Forecast (2020-2026)
13.2.3 Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Market Forecast (2020-2026)
13.2.4 Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Market Forecast (2020-2026)
13.2.5 South America Nuclear Medicine-Radiopharmaceuticals Market Forecast (2020-2026)
13.3 Nuclear Medicine-Radiopharmaceuticals Market Forecast by Types (2020-2026)
13.4 Nuclear Medicine-Radiopharmaceuticals Market Forecast by Applications (2020-2026)
13.5 Nuclear Medicine-Radiopharmaceuticals Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
List of Tables and Figures
Table Global Nuclear Medicine-Radiopharmaceuticals Market Size Growth Rate by Type (2020-2026)
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Type in 2019 & 2026
Figure Diagnostic Medicine Features
Figure Therapeutic Medicine Features
Table Global Nuclear Medicine-Radiopharmaceuticals Market Size Growth by Application (2020-2026)
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Share by Application in 2019 & 2026
Figure SPECT Description
Figure PET Description
Figure Therapeutic Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Nuclear Medicine-Radiopharmaceuticals Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate 2015-2026
Table Industry News
Table Industry Policies
Figure Value Chain Status of Nuclear Medicine-Radiopharmaceuticals
Figure Production Process of Nuclear Medicine-Radiopharmaceuticals
Figure Manufacturing Cost Structure of Nuclear Medicine-Radiopharmaceuticals
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Alliance Medical (UK) Profile
Table Alliance Medical (UK) Production, Value, Price, Gross Margin 2015-2020
Table Bayer HealthCare Medical Care (US) Profile
Table Bayer HealthCare Medical Care (US) Production, Value, Price, Gross Margin 2015-2020
Table Lantheus Medical Imaging Inc (US) Profile
Table Lantheus Medical Imaging Inc (US) Production, Value, Price, Gross Margin 2015-2020
Table Positron Corporation (US) Profile
Table Positron Corporation (US) Production, Value, Price, Gross Margin 2015-2020
Table Alseres Pharmaceuticals, Inc (US) Profile
Table Alseres Pharmaceuticals, Inc (US) Production, Value, Price, Gross Margin 2015-2020
Table Ion Beam Applications S.A (Belgium) Profile
Table Ion Beam Applications S.A (Belgium) Production, Value, Price, Gross Margin 2015-2020
Table Nordion, Inc. (Canada) Profile
Table Nordion, Inc. (Canada) Production, Value, Price, Gross Margin 2015-2020
Table Avid Radiopharmaceuticals (US) Profile
Table Avid Radiopharmaceuticals (US) Production, Value, Price, Gross Margin 2015-2020
Table Actinium Pharmaceuticals Inc (US) Profile
Table Actinium Pharmaceuticals Inc (US) Production, Value, Price, Gross Margin 2015-2020
Table Mallinckrodt Pharmaceuticals (Ireland) Profile
Table Mallinckrodt Pharmaceuticals (Ireland) Production, Value, Price, Gross Margin 2015-2020
Table Siemens Healthcare (US) Profile
Table Siemens Healthcare (US) Production, Value, Price, Gross Margin 2015-2020
Table Cardinal Health, Inc (US) Profile
Table Cardinal Health, Inc (US) Production, Value, Price, Gross Margin 2015-2020
Table Advanced Medical Isotope Corporation (US) Profile
Table Advanced Medical Isotope Corporation (US) Production, Value, Price, Gross Margin 2015-2020
Table Immunomedics, Inc. (US) Profile
Table Immunomedics, Inc. (US) Production, Value, Price, Gross Margin 2015-2020
Table Bracco Imaging S.p.A (Italy) Profile
Table Bracco Imaging S.p.A (Italy) Production, Value, Price, Gross Margin 2015-2020
Table Triad Isotopes, Inc. (US) Profile
Table Triad Isotopes, Inc. (US) Production, Value, Price, Gross Margin 2015-2020
Table Peregrine Pharmaceuticals, Inc. (US) Profile
Table Peregrine Pharmaceuticals, Inc. (US) Production, Value, Price, Gross Margin 2015-2020
Table GE Healthcare (UK) Profile
Table GE Healthcare (UK) Production, Value, Price, Gross Margin 2015-2020
Table Medi-Radiopharma Ltd (Hungary) Profile
Table Medi-Radiopharma Ltd (Hungary) Production, Value, Price, Gross Margin 2015-2020
Table Jubilant Pharma (India) Profile
Table Jubilant Pharma (India) Production, Value, Price, Gross Margin 2015-2020
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales by Regions (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue ($) by Regions (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions in 2015
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Regions in 2019
Figure North America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure North America Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth (2015-2020)
Table North America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
Table North America Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Figure North America Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries in 2015
Figure North America Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries in 2019
Table North America Nuclear Medicine-Radiopharmaceuticals Revenue ($) by Countries (2015-2020)
Table North America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure North America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries in 2015
Figure North America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure United States Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Canada Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Mexico Nuclear Medicine-Radiopharmaceuticals Sales and Growth (2015-2020)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue ($) Growth (2015-2020)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
Table Europe Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries in 2015
Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries in 2019
Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue ($) by Countries (2015-2020)
Table Europe Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries in 2015
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure Germany Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure UK Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure France Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Italy Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Spain Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Russia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth (2015-2020)
Table Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
Table Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries in 2015
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries in 2019
Table Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Revenue ($) by Countries (2015-2020)
Table Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries in 2015
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure China Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Japan Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure South Korea Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Australia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure India Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth (2015-2020)
Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue ($) by Countries (2015-2020)
Table Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries in 2015
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure UAE Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Egypt Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Nigeria Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure South Africa Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure South America Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth (2015-2020)
Table South America Nuclear Medicine-Radiopharmaceuticals Sales by Countries (2015-2020)
Table South America Nuclear Medicine-Radiopharmaceuticals Sales Market Share by Countries (2015-2020)
Table South America Nuclear Medicine-Radiopharmaceuticals Revenue ($) by Countries (2015-2020)
Table South America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure South America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries in 2015
Figure South America Nuclear Medicine-Radiopharmaceuticals Revenue Market Share by Countries in 2019
Figure Brazil Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Argentina Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Columbia Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Figure Chile Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales by Types (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Share by Types (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue ($) by Types (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Share by Types (2015-2020)
Figure Global Diagnostic Medicine Sales and Growth Rate (2015-2020)
Figure Global Diagnostic Medicine Price (2015-2020)
Figure Global Therapeutic Medicine Sales and Growth Rate (2015-2020)
Figure Global Therapeutic Medicine Price (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales by Applications (2015-2020)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Share by Applications (2015-2020)
Figure Global SPECT Sales and Growth Rate (2015-2020)
Figure Global SPECT Revenue and Growth Rate (2015-2020)
Figure Global PET Sales and Growth Rate (2015-2020)
Figure Global PET Revenue and Growth Rate (2015-2020)
Figure Global Therapeutic Sales and Growth Rate (2015-2020)
Figure Global Therapeutic Revenue and Growth Rate (2015-2020)
Figure Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate (2020-2026)
Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2020-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Regions (2020-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Forecast by Regions (2020-2026)
Figure North America Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2020-2026)
Figure North America Nuclear Medicine-Radiopharmaceuticals Revenue Forecast (2020-2026)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2020-2026)
Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue Forecast (2020-2026)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2020-2026)
Figure Asia-Pacific Nuclear Medicine-Radiopharmaceuticals Revenue Forecast (2020-2026)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2020-2026)
Figure Middle East and Africa Nuclear Medicine-Radiopharmaceuticals Revenue Forecast (2020-2026)
Figure South America Nuclear Medicine-Radiopharmaceuticals Sales Forecast (2020-2026)
Figure South America Nuclear Medicine-Radiopharmaceuticals Revenue Forecast (2020-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Types (2020-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Market Share Forecast by Types (2020-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Forecast by Types (2020-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share Forecast by Types (2020-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Forecast by Applications (2020-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Sales Market Share Forecast by Applications (2020-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Forecast by Applications (2020-2026)
Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Market Share Forecast by Applications (2020-2026)
Global Surgical Overalls Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Surgical Overalls market was valued at US$ 679.9 million in 2023 and is anticipated to reach US$ 870.5 million by 2030, witnessing a CAGR of 3.1% during The forecast period 2024-2030.
According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in recent years ......
Global Medical or Healthcare Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Medical or Healthcare market size was valued at US$ million in 2023. With growing demand in downstream market, the Medical or Healthcare is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Medical or Healthcare market. Medical or Healthcare are expected to show stable growth in the future market. However, product differ......
Global Hospital Gas Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 100
According to our LPI (LP Information) latest study, the global Hospital Gas market size was valued at US$ million in 2023. With growing demand in downstream market, the Hospital Gas is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hospital Gas market. Hospital Gas are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Nurse Call Systems Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 135
According to our LPI (LP Information) latest study, the global Nurse Call Systems market size was valued at US$ 1633.1 million in 2023. With growing demand in downstream market, the Nurse Call Systems is forecast to a readjusted size of US$ 3280.4 million by 2030 with a CAGR of 10.5% during review period.
The research report highlights the growth potential of the global Nurse Call Systems market. Nurse Call Systems are expected to show stable growth in the future market. However, product......
Global Pediatric Healthcare Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 118
According to our LPI (LP Information) latest study, the global Pediatric Healthcare market size was valued at US$ 136230 million in 2023. With growing demand in downstream market, the Pediatric Healthcare is forecast to a readjusted size of US$ 177330 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Pediatric Healthcare market. Pediatric Healthcare are expected to show stable growth in the future market. However, ......
Global Telepharmacy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 100
Market Overview of Global Telepharmacy market:
According to our latest research, the global Telepharmacy market looks promising in the next 5 years. As of 2022, the global Telepharmacy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Telepharmacy market, with a systema......
Global Vinca Alkaloid Compounds Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 115
Market Overview of Global Vinca Alkaloid Compounds market:
According to our latest research, the global Vinca Alkaloid Compounds market looks promising in the next 5 years. As of 2022, the global Vinca Alkaloid Compounds market was estimated at USD 26.93 million, and it's anticipated to reach USD 44.76 million in 2028, with a CAGR of 8.84% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of th......
Global Bladder Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 116
Market Overview of Global Bladder Cancer market:
According to our latest research, the global Bladder Cancer market looks promising in the next 5 years. As of 2022, the global Bladder Cancer market was estimated at USD 3886.47 million, and it's anticipated to reach USD 13709.57 million in 2028, with a CAGR of 23.38% during the forecast years.
Bladder cancer is a disease in which cells in the urinary bladder start growing abnormally and uncontrollably. The main types of bladde......
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 115
Market Overview of Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market:
According to our latest research, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market looks promising in the next 5 years. As of 2022, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
